Neonatal Bacterial Infection Clinical Trial
Official title:
Value for Cord Blood Procalcitonin to Diagnose Early Neonatal Bacterial Infection
After birth, in the presence of risk factors for early neonatal bacterial infection (IBNP),
the pediatrician must make a difficult decision quickly or not to prescribe additional
examinations and / or hospitalize or not the newborn in order to administer parenteral
antibiotics. This decision takes into account several contextual data, (clinical, biological
and bacteriological clinical data) to be considered simultaneously. These information lack
sensitivity and specificity.
Therefore, the common attitude among newborns in many countries remains the achievement of a
significant number of additional tests and the establishment, without a prior evidence of
infection, intravenous empirical antibiotic therapy for 48 -72h at least in hospitalization.
However, the diagnosis of IBNP posteriori, is often reversed. This attitude is:
1. one source to higher health care costs (hospitalization, additional examinations)
2. Selection of the bacterial ecology of the newborn and neonatal services and
3. stress for the newborn and parents
n/a
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic